UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Building global development strategies for cf therapeutics during a transitional cftr modulator era

Journal of cystic fibrosis, 2020-09, Vol.19 (5), p.677-687

2020

Volltextzugriff (PDF)

In-plane MEMS-based nano-g accelerometer with sub-wavelength optical resonant sensor

Sensors and actuators. A. Physical., 2008-07, Vol.145-146, p.283-290

2008

Volltextzugriff (PDF)

Significant Microbiological Effect of Inhaled Tobramycin in Young Children with Cystic Fibrosis

American journal of respiratory and critical care medicine, 2003-03, Vol.167 (6), p.841-849

2003

Volltextzugriff (PDF)

Orchestrations of consciousness in the universe: Consciousness and electronic music applied to Xenolinguistics and Adnyamathanha aboriginal songs

Technoetic arts : a journal of speculative research, 2018-03, Vol.16 (1), p.113-131

Van De Bogart, Willard G.

2018

Volltextzugriff (PDF)

A pilot study of children's exposure to CCA-treated wood from playground equipment

The Science of the total environment, 2006-08, Vol.367 (1), p.80-88

2006

Volltextzugriff (PDF)

Crystalline silicon tilting mirrors for optical cross-connect switches

Journal of microelectromechanical systems, 2003-10, Vol.12 (5), p.708-712

2003

Volltextzugriff (PDF)

WS5.4 Aztreonam for inhalation solution (AZLI) in cystic fibrosis (CF) patients with chronic Burkholderia species ( BURK ) infection: final results from a randomized, placebo-controlled trial

Journal of cystic fibrosis, 2012-06, Vol.11, p.S11-S11

2012

Volltextzugriff (PDF)

58 No antibiotic cross-resistance after 1 year of continuous aztreonam for inhalation solution (AZLI) in cystic fibrosis (CF) patients (pts) with chronic Burkholderia (BURK) infection

Journal of cystic fibrosis, 2012-06, Vol.11, p.S71-S71

2012

Volltextzugriff (PDF)

Inflammatory and Microbiologic Markers in Induced Sputum after Intravenous Antibiotics in Cystic Fibrosis

American journal of respiratory and critical care medicine, 2003-12, Vol.168 (12), p.1471-1475

2003

Volltextzugriff (PDF)

Long term results of lung transplantation for cystic fibrosis

European journal of cardio-thoracic surgery, 2002-10, Vol.22 (4), p.602-609

2002

Volltextzugriff (PDF)

148 Long-term safety and efficacy of elexacaftor/tezacaftor/ivacaftor in children aged 6 and older with cystic fibrosis and at least one F508del allele: final results from a 192-week extension study

Journal of cystic fibrosis, 2024-09, Vol.23, p.S82-S83

2024

Volltextzugriff (PDF)

47: A new path for CF clinical trials through the use of historical controls

Journal of cystic fibrosis, 2021-11, Vol.20, p.S24

2021

Volltextzugriff (PDF)

133 Long-term safety and efficacy of elexacaftor-tezacaftor-ivacaftor in children aged 6 and older with cystic fibrosis and at least one F508del allele: 144-week results of an open-label extension study

Journal of cystic fibrosis, 2023-10, Vol.22, p.S70-S71

2023

Volltextzugriff (PDF)

84 Aztreonam 75 mg powder and solvent for nebuliser solution (AZLI) in cystic fibrosis (CF) patients with chronic Burkholderia species (Burk) infection: baseline demographics and microbiology from a randomized, placebo-controlled trial

Journal of cystic fibrosis, 2011, Vol.10, p.S22-S22

2011

Volltextzugriff (PDF)

788 Increasing screening rates for CF-related diabetes in a pediatric CF program

Journal of cystic fibrosis, 2024-09, Vol.23, p.S453-S453

2024

Volltextzugriff (PDF)

C67 SUPPURATIVE LUNG DISEASES IN CHILDREN: Lci In Symptomatic Preschool Children With Cystic Fibrosis

American journal of respiratory and critical care medicine, 2017-01, Vol.195

2017

Volltextzugriff (PDF)

Comparative efficacy and safety of four randomized regimens to treat early Pseudomonas aeruginosa infection in children with cystic fibrosis

Journal of cystic fibrosis, 2010, Vol.9, p.S54-S54

2010

Volltextzugriff (PDF)

Diffractive x-ray optics using production fabrication methods

Environmental science & technology, 2003-01, Vol.21 (1), p.214-219

2003

Volltextzugriff (PDF)

WS07-3 Effect of cumulative bacterial infection on the Lung Clearance Index in preschool children with cystic fibrosis

Journal of cystic fibrosis, 2019-06, Vol.18, p.S13-S13

2019

Volltextzugriff (PDF)

163 Long-term safety and efficacy of elexacaftor/tezacaftor/ivacaftor in children 6 years and older with cystic fibrosis and at least one F508del alleles: 96-week interim results from an open-label extension study

Journal of cystic fibrosis, 2022-10, Vol.21, p.S96-S96

2022

Volltextzugriff (PDF)

Effect of multiple aztreonam lysine for inhalation (AZLI) cycles on disease-related endpoints and safety in patients with cystic fibrosis (CF) and Pseudomonas aeruginosa (PA): Interim analysis of 12 month data

Journal of cystic fibrosis, 2008-06, Vol.7, p.S25-S25

2008

Volltextzugriff (PDF)

Microbiologic resistance and clinical efficacy of aztreonam lysine for inhalation (AZLI) in cystic fibrosis (CF)

Journal of cystic fibrosis, 2008-06, Vol.7, p.S36-S36

2008

Volltextzugriff (PDF)

Fixed polarizer ellipsometry for simple and sensitive detection of thin films generated by specific molecular interactions: applications in immunoassays and DNA sequence detection

Clinical chemistry (Baltimore, Md.), 1998-09, Vol.44 (9), p.2031-2035

1998

Volltextzugriff (PDF)

Inhaled Aztreonam Lysine for Chronic Airway Pseudomonas aeruginosa in Cystic Fibrosis

American journal of respiratory and critical care medicine, 2008-11, Vol.178 (9), p.921-928

2008

Volltextzugriff (PDF)

Pseudomonas aeruginosa antibiotic susceptibility during long-term use of aztreonam for inhalation solution (AZLI)

Journal of antimicrobial chemotherapy, 2011-10, Vol.66 (10), p.2398-2404

2011

Volltextzugriff (PDF)

1 – 25 von 496

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(411)
Mit Volltextzugriff
(418)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Building global development strategies for cf therapeutics during a transitional cftr modulator era

In-plane MEMS-based nano-g accelerometer with sub-wavelength optical resonant sensor

Significant Microbiological Effect of Inhaled Tobramycin in Young Children with Cystic Fibrosis

Orchestrations of consciousness in the universe: Consciousness and electronic music applied to Xenolinguistics and Adnyamathanha aboriginal songs

A pilot study of children's exposure to CCA-treated wood from playground equipment

Crystalline silicon tilting mirrors for optical cross-connect switches

WS5.4 Aztreonam for inhalation solution (AZLI) in cystic fibrosis (CF) patients with chronic Burkholderia species ( BURK ) infection: final results from a randomized, placebo-controlled trial

58 No antibiotic cross-resistance after 1 year of continuous aztreonam for inhalation solution (AZLI) in cystic fibrosis (CF) patients (pts) with chronic Burkholderia (BURK) infection

Inflammatory and Microbiologic Markers in Induced Sputum after Intravenous Antibiotics in Cystic Fibrosis

Long term results of lung transplantation for cystic fibrosis

148 Long-term safety and efficacy of elexacaftor/tezacaftor/ivacaftor in children aged 6 and older with cystic fibrosis and at least one F508del allele: final results from a 192-week extension study

47: A new path for CF clinical trials through the use of historical controls

133 Long-term safety and efficacy of elexacaftor-tezacaftor-ivacaftor in children aged 6 and older with cystic fibrosis and at least one F508del allele: 144-week results of an open-label extension study

84 Aztreonam 75 mg powder and solvent for nebuliser solution (AZLI) in cystic fibrosis (CF) patients with chronic Burkholderia species (Burk) infection: baseline demographics and microbiology from a randomized, placebo-controlled trial

788 Increasing screening rates for CF-related diabetes in a pediatric CF program

C67 SUPPURATIVE LUNG DISEASES IN CHILDREN: Lci In Symptomatic Preschool Children With Cystic Fibrosis

Comparative efficacy and safety of four randomized regimens to treat early Pseudomonas aeruginosa infection in children with cystic fibrosis

Diffractive x-ray optics using production fabrication methods

WS07-3 Effect of cumulative bacterial infection on the Lung Clearance Index in preschool children with cystic fibrosis

163 Long-term safety and efficacy of elexacaftor/tezacaftor/ivacaftor in children 6 years and older with cystic fibrosis and at least one F508del alleles: 96-week interim results from an open-label extension study

Effect of multiple aztreonam lysine for inhalation (AZLI) cycles on disease-related endpoints and safety in patients with cystic fibrosis (CF) and Pseudomonas aeruginosa (PA): Interim analysis of 12 month data

Microbiologic resistance and clinical efficacy of aztreonam lysine for inhalation (AZLI) in cystic fibrosis (CF)

Fixed polarizer ellipsometry for simple and sensitive detection of thin films generated by specific molecular interactions: applications in immunoassays and DNA sequence detection

Inhaled Aztreonam Lysine for Chronic Airway Pseudomonas aeruginosa in Cystic Fibrosis

Pseudomonas aeruginosa antibiotic susceptibility during long-term use of aztreonam for inhalation solution (AZLI)

Suchergebnisse filtern